Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53

567 views

VJOncology

1 year ago

Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53

Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53